
News|Articles|January 2, 2014
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-01-08-2014
- Volume 10
- Issue 1
BMS Grants Support Mental Health Needs of US Military Veterans
Author(s)Melanie Sena
The Bristol-Myers Squibb Foundation is awarding 10 grants to fund programs for veterans and their families.
Advertisement
The
The Foundation’s 2013 Mental Health and Well-Being grant recipients are:
- New York Legal Assistance Group and Connecticut Veterans Legal Clinic will receive two-year grants to partner with the Department of Veterans Affairs (VA) to study how civil legal services impact mental health and quality of life outcomes for veterans treated in VA mental health and homeless programs.
- Points of Light, National Council for Behavioral Health, and Massachusetts General Hospital will each receive two-year grants to partner with Outside the Wire on its Theater of War performances to military and civilian audiences in 25 US cities. Outside the Wire is a social impact company that uses theater to address a number of pressing public health issues.
- Minnesota Veterans Medical Research and Education Foundation will receive a two-year grant for a new program called Building Spiritual Strength that will use pastoral counselors to address the issues of moral injury – killing or wounding others – among combat trauma survivors.
- Rush University Medical Center Department of Behavioral Sciences will receive a one-year grant to complete an efficacy trial of the mental health services provided by Vets Prevail and recruit and enroll more than 6,200 additional veterans into the program, which received funding from the Foundation last year.
- Boston University School of Public Health will receive a two-year grant to transform a pilot version of a self-directed, web-based intervention that focuses on self-management to control alcohol consumption as a critical approach to managing PTSD into a consumer-ready version.
- National Alliance on Mental Illness (NAMI) received a three-year matching grant to adapt the evidence-based NAMI Family-to-Family Education Program to the needs of families of active duty military personnel and veterans.
- Carter Center received a grant to conduct the Mental Health & Well-Being Grantees Summit in Atlanta, Georgia, in June 2013.
Source:
Articles in this issue
almost 13 years ago
New Dynamics in Drug Pricing and Prescribingalmost 13 years ago
Climate Change Drives New Opportunities in Outsourcingalmost 13 years ago
Jimmy Carter and Pfizer Mark 15-Year Effort To Help End Blinding Trachomaalmost 13 years ago
Pall Corporation to Acquire ATMI's LifeSciences Business for $185 millionalmost 13 years ago
Cambrex Completes FDA Inspectionalmost 13 years ago
Metrics Appoints New Vice-Presidentalmost 13 years ago
Bridgepoint Development Capital Acquires Quotient Clinicalalmost 13 years ago
GDUFA Off to Good Start, But Storm Clouds on the HorizonAdvertisement
Related to this article

Richard Jaenisch explains what FDA's real-world use case database means for CMC and quality teams navigating NAMs.

Boyang Wang, Immortal Dragons, explains how FDA’s Expedited IND Pilot and research partners could speed serial steps to first-in-human trials compared to China’s 818 Decree.

This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating manufacturing systems, centralized data management, Industrial Internet of Things connectivity, electronic batch production records, and AI-driven analytics.

PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.

Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.

The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.

This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
What the Olanzapine Depot Approval Means for CMC Teams
3
Q&A: Patient-Centric Drug Development Should Start at Product Definition
4
PharmTech Weekly Roundup—Oct. 8, 2026: CPHI Highlights
5


